Point72 Asset Management
TXG icon

Point72 Asset Management’s 10x Genomics TXG Stock Holding History

Point72 Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,230,189
Closed -$27.8M – 2464
2024
Q3 		$27.8M Buy
+1,230,189
New +$25.4M 0.07% 323
2024
Q1 		– Sell
-497,282
Closed -$27.8M – 2635
2023
Q4 		$27.8M Sell
497,282
-850,137
-63% -$37M 0.07% 342
2023
Q3 		$55.6M Sell
1,347,419
-255,749
-16% -$13.3M 0.16% 149
2023
Q2 		$89.5M Buy
1,603,168
+1,066,837
+199% +$57.7M 0.27% 88
2023
Q1 		$29.9M Buy
+536,331
New +$25M 0.09% 261
2022
Q1 		– Sell
-171,462
Closed -$25.5M – 1399
2021
Q4 		$25.5M Buy
+171,462
New +$26.3M 0.1% 289
2021
Q2 		– Sell
-23,860
Closed -$4.32M – 1176
2021
Q1 		$4.32M Sell
23,860
-185,878
-89% -$32.1M 0.02% 600
2020
Q4 		$29.7M Buy
209,738
+112,661
+116% +$16.3M 0.14% 198
2020
Q3 		$12.1M Buy
97,077
+55,992
+136% +$5.88M 0.06% 371
2020
Q2 		$3.67M Sell
41,085
-213,960
-84% -$16.7M 0.02% 523
2020
Q1 		$15.9M Buy
+255,045
New +$19.9M 0.13% 233
2019
Q4 		– Sell
-400
Closed -$20K – 1261
2019
Q3 		$20K Buy
+400
New +$22.1K ﹤0.01% 1073

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management's TXG Position: Q4 2024 in Review

Point72 Asset Management sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 1,230,189 shares — an estimated $27.8M sold.

Point72 Asset Management first reported a position in TXG in Q3 2019 and held it in 12 quarters. The position peaked at $89.5M in Q2 2023. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Point72 Asset Management reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Point72 Asset Management sold 1,230,189 10x Genomics shares in Q4 2024, an estimated $27.8M.
  • Point72 Asset Management first reported a position in 10x Genomics in Q3 2019 and held it in 12 quarters.
  • Point72 Asset Management's 10x Genomics position peaked at $89.5M in Q2 2023.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.